Navigation Links
Novavax Announces Manufacturing Management Appointments
Date:6/14/2010

r Director of Virology and Animal Biology at Elusys Therapeutics, where he helped develop monoclonal-based therapeutics to treat infectious diseases, and Senior Research Scientist with Virogenetics, where he developed a number of poxvirus recombinant vaccines and served on project teams that evaluated these candidates in Phase I clinical trials.

About Novavax, Inc.

Novavax, Inc. is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology.  The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches.  Novavax is committed to using its VLP technology to create country-specific vaccine solutions.  The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India.  Additional information about Novavax is available on the company's website: www.novavax.com.  

Safe-Harbor Statement

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding revenue, operating expenses, use of cash, manufacturing developments, and commercial developments are forward-looking statements within the meaning of the Private Securities Litigation Reform Act.  Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncert
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. Novavax Reports First Quarter 2008 Financial Results
8. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
9. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
10. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
11. Novavax to Join Russell 3000 Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... , August 5, 2015 ... size is expected to reach USD 6.24 billion ... Grand View Research, Inc. The Increasing demand for ... are expected to drive the cell line development ... (Logo: http://photos.prnewswire.com/prnh/20150105/723757) , Increasing prevalence of ...
(Date:8/5/2015)... ... August 05, 2015 , ... ... and assessment of more organotypic 3D cell culture models, announced today that its ... (ULA) Plates are now available for purchase exclusively through PerkinElmer.     , InSphero ...
(Date:8/4/2015)... ... 04, 2015 , ... Graphite Metallizing Corporation, the manufacturer of ... appointment of Dennis Rawle as European Director of Sales. Rawle has over 25 ... General Manager and Technical Sales Manager for pump products at Exalto UK. Rawle ...
(Date:8/4/2015)... , Aug. 4, 2015  Blueprint Medicines (NASDAQ: ... selective kinase drugs for genomically defined diseases, today announced ... present a company overview at the 2015 Wedbush PacGrow ... p.m. EDT. A live webcast of the ... of the Blueprint Medicines website at www.blueprintmedicines.com . ...
Breaking Biology Technology:Cell Line Development Market To Reach $6.24 Billion By 2022: Grand View Research, Inc. 2Cell Line Development Market To Reach $6.24 Billion By 2022: Grand View Research, Inc. 3Cell Line Development Market To Reach $6.24 Billion By 2022: Grand View Research, Inc. 4Cell Line Development Market To Reach $6.24 Billion By 2022: Grand View Research, Inc. 5InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms 2InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms 3Dennis Rawle Joins Graphite Metallizing Corporation 2
... MINNEAPOLIS, May 9 ATS Medical, Inc. (Nasdaq:,ATSI), ... announced that it will participate at the Rodman ... Le Meridien Beach Plaza,Hotel in Monte Carlo on ... of ATS Medical, will present at 9:20 a.m. ...
... Inc. (OTC,Bulletin Board: PLMO) announced today that it ... taking its total holdings to 61% in this ... for pulmonary,related medical conditions., Pulmo BioTech CEO ... technology, developed and owned by PulmoScience, will dominate ...
... Pharmaceuticals today,announced that Scott Jackson has been appointed ... 2007 as Head of Commercial,Development., "We are ... He brings more than 20,years of pharmaceutical experience, ... oncology," said Dr. Joseph Mollica,Chairman of Celator,s Board ...
Cached Biology Technology:ATS Medical to Participate at the Rodman & Renshaw 5th Annual Global Healthcare Conference 2Pulmo BioTech Announces an Increase in its Stake in PulmoScience 2Pulmo BioTech Announces an Increase in its Stake in PulmoScience 3Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO 2
(Date:7/31/2015)... China , 31. Juli 2015 Die 10. ... wird von BGI veranstaltet und findet vom 22. ... China , statt. Die ... Seit ihrem Start 2006 ist die ICG weltweit ... „omik" geworden. Sie ist eines der dynamischsten, enthusiastischsten ...
(Date:7/27/2015)... ANGELES , July 27, 2015   ... evidence- and experience-based clinical improvement solutions, today announced ... solution is now available on Android smartphones and ... inpatient and post-care organizations can use ZynxCarebook to ... same patient,s condition, streamline care transitions to other ...
(Date:7/21/2015)... 21, 2015 Passwords have proven futile ... the recent U.S. Office of Personnel Management breach. ... infosec conundrum, but developers and end-users are concerned ... this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced today ... for third party integration. A ...
Breaking Biology News(10 mins):Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4
... Can the hold that Intelligent Design theorists have in ... a leading American evolutionist, makes the case for Darwin ... Reporting from the front lines of America's struggle over ... (University College London) on 16th November. , In his ...
... inoculate everyone in the United States could be grown ... plants, a University of Central Florida molecular biologist has ... UCF professor Henry Daniell's laboratory through the genetic engineering ... later by National Institutes of Health researchers. The results ...
... special green-algae gene into neurons of the tiny, ... to elicit specific behavioral responses by simply illuminating ... way for better understanding of how neurons communicate ... behavior in intact, living organisms. Generally speaking, detailed ...
Cached Biology News:'Creationism is not science' ?making the case for Darwin at UCL 2Effective, safe anthrax vaccine can be grown in tobacco plants 2Effective, safe anthrax vaccine can be grown in tobacco plants 3Algal protein in worm neurons allows remote control of behavior by light 2
... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
... Preparation Note: Prepared by a ... C.W., et al., Biotechnol. Bioeng., ... Definition: One unit will yield an ... 1.0 ml of water (1 cm ...
... Dithiothreitol DTT White ... reduces disulfides to thiols, so reaction is "driven" ... Does not contain waxy surfactant found in many ... of pentobarbitol. Purity: ≥97% by titration. ...
... stains are $6.00 and ``silver`` (along ... are $9.00. This price includes ... coverslipping and labeling of the slide. ... Stain ,Copper Stain ,Fontana-Masson Stain for ...
Biology Products: